Menu
GeneBe

rs56286620

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_002253.4(KDR):c.1384T>G(p.Leu462Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,613,950 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 6 hom. )

Consequence

KDR
NM_002253.4 missense

Scores

3
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:2O:1

Conservation

PhyloP100: 0.293
Variant links:
Genes affected
KDR (HGNC:6307): (kinase insert domain receptor) Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004890412).
BP6
Variant 4-55107765-A-C is Benign according to our data. Variant chr4-55107765-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 134602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd at 255 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KDRNM_002253.4 linkuse as main transcriptc.1384T>G p.Leu462Val missense_variant 10/30 ENST00000263923.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KDRENST00000263923.5 linkuse as main transcriptc.1384T>G p.Leu462Val missense_variant 10/301 NM_002253.4 P1P35968-1
KDRENST00000512566.1 linkuse as main transcriptn.1384T>G non_coding_transcript_exon_variant 10/131
KDRENST00000647068.1 linkuse as main transcriptn.1397T>G non_coding_transcript_exon_variant 10/30

Frequencies

GnomAD3 genomes
AF:
0.00168
AC:
255
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00641
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00216
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00149
AC:
373
AN:
251080
Hom.:
1
AF XY:
0.00148
AC XY:
201
AN XY:
135708
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00615
Gnomad NFE exome
AF:
0.00189
Gnomad OTH exome
AF:
0.000981
GnomAD4 exome
AF:
0.00189
AC:
2767
AN:
1461672
Hom.:
6
Cov.:
32
AF XY:
0.00189
AC XY:
1375
AN XY:
727150
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00504
Gnomad4 NFE exome
AF:
0.00217
Gnomad4 OTH exome
AF:
0.000944
GnomAD4 genome
AF:
0.00167
AC:
255
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.000529
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00641
Gnomad4 NFE
AF:
0.00216
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00186
Hom.:
0
Bravo
AF:
0.00124
ExAC
AF:
0.00135
AC:
164
EpiCase
AF:
0.00147
EpiControl
AF:
0.00107

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2023KDR: BP4, BS1 -
Benign, criteria provided, single submitterclinical testingInvitaeDec 31, 2019- -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The KDR p.Leu462Val variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs56286620) and ClinVar (submitted by ITMI with no classification). The variant was identified in control databases in 420 of 282462 chromosomes (1 homozygous) at a frequency of 0.001487 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (Finnish) in 151 of 25100 chromosomes (freq: 0.006016), European (non-Finnish) in 240 of 128880 chromosomes (freq: 0.001862), Other in 7 of 7206 chromosomes (freq: 0.000971), African in 15 of 24956 chromosomes (freq: 0.000601) and Latino in 7 of 35406 chromosomes (freq: 0.000198), but was not observed in the Ashkenazi Jewish, East Asian, and South Asian populations. The p.Leu462 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 2 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
not specified Other:1
not provided, no classification providedreference populationITMISep 19, 2013- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
Cadd
Benign
13
Dann
Uncertain
0.99
DEOGEN2
Benign
0.072
T;T
Eigen
Benign
-0.048
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.91
D
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Uncertain
2.4
M;M
MutationTaster
Benign
0.76
D
PrimateAI
Benign
0.30
T
Polyphen
0.86
P;P
Vest4
0.51
MVP
0.33
MPC
0.42
ClinPred
0.037
T
GERP RS
-0.73
Varity_R
0.18
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56286620; hg19: chr4-55973932; API